The observed down-regulation of CD95 may indeed play an important role in biological aggressiveness of pancreatic tumours, since just recently Bernstorff et al. (2002) reported a reduced membranous CD95 staining in tissue sections of invasive ductal adenocarcinomas compared to normal pancreatic tissue. Here, FAS is linked to invasive ductal breast carcinoma.